Yi Miao

2.1k total citations
64 papers, 1.3k citations indexed

About

Yi Miao is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Yi Miao has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 31 papers in Genetics and 23 papers in Oncology. Recurrent topics in Yi Miao's work include Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Viral-associated cancers and disorders (11 papers). Yi Miao is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Viral-associated cancers and disorders (11 papers). Yi Miao collaborates with scholars based in China, United States and Switzerland. Yi Miao's co-authors include Jianyong Li, L. Jeffrey Medeiros, Ken H. Young, Yong Li, Lei Fan, Jia‐Zhu Wu, Wei Xu, Yi Zhu, Wei Li and Zekuan Xu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yi Miao

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Miao China 19 437 410 396 302 236 64 1.3k
Ewa Lech‐Marańda Poland 25 479 1.1× 421 1.0× 493 1.2× 511 1.7× 437 1.9× 134 1.7k
Patricia Tsang United States 20 363 0.8× 304 0.7× 336 0.8× 250 0.8× 102 0.4× 30 1.1k
Juraj Bodo United States 17 406 0.9× 354 0.9× 665 1.7× 429 1.4× 240 1.0× 48 1.3k
Vassilios I. Avramis United States 31 215 0.5× 454 1.1× 1.2k 3.0× 266 0.9× 171 0.7× 68 3.0k
Markus Jensen Germany 10 396 0.9× 330 0.8× 203 0.5× 319 1.1× 496 2.1× 17 1.3k
Todd Busman United States 20 514 1.2× 655 1.6× 1.5k 3.7× 681 2.3× 415 1.8× 42 2.6k
Utz Krug Germany 25 177 0.4× 432 1.1× 1.1k 2.8× 282 0.9× 233 1.0× 82 2.0k
Barry L. Gause United States 21 279 0.6× 851 2.1× 530 1.3× 131 0.4× 1.1k 4.7× 40 1.9k
S.A. Johnson United Kingdom 21 587 1.3× 456 1.1× 411 1.0× 774 2.6× 716 3.0× 35 2.0k
Franklin C. Harwood United States 16 131 0.3× 547 1.3× 919 2.3× 213 0.7× 87 0.4× 17 1.4k

Countries citing papers authored by Yi Miao

Since Specialization
Citations

This map shows the geographic impact of Yi Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Miao more than expected).

Fields of papers citing papers by Yi Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Miao. The network helps show where Yi Miao may publish in the future.

Co-authorship network of co-authors of Yi Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Miao. A scholar is included among the top collaborators of Yi Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Miao. Yi Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Qingqing, Jing Zhang, Huijun Huang, et al.. (2024). Histiocytic necrotizing lymphadenitis with hemophagocytic lymphohistiocytosis in adults: A single‐center analysis of 5 cases. Immunity Inflammation and Disease. 12(2). e1202–e1202. 1 indexed citations
3.
Zhang, Jing, Qingqing Chen, Yi Xia, et al.. (2023). The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology. 43(6). 1302–1310. 9 indexed citations
4.
Miao, Yi, Yue Li, Jin‐Hua Liang, et al.. (2023). Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia. Clinical and Experimental Medicine. 23(6). 2651–2662. 5 indexed citations
5.
Zhang, Jing, et al.. (2022). Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma. Biomarker Research. 10(1). 17–17. 15 indexed citations
6.
Zhang, Jing, Hui Shen, Lu He, et al.. (2021). Association of marital status with stage and survival in patients with mycosis fungoides: A population‐based study. Cancer Medicine. 10(20). 7320–7329. 5 indexed citations
7.
Du, Xinyi, Hailing Liu, Changqing Yang, et al.. (2021). LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia. Leukemia Research. 110. 106706–106706. 10 indexed citations
8.
Wu, Jia‐Zhu, Yi Miao, Xicheng Wang, et al.. (2021). Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study. Journal of Cancer. 12(10). 2903–2911. 14 indexed citations
9.
Liu, Xinjian, Hao Yuan, Jing Zhou, et al.. (2021). LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and Metastasis. Frontiers in Cell and Developmental Biology. 9. 647387–647387. 18 indexed citations
10.
Miao, Yi, Yixin Zou, Danling Gu, et al.. (2019). SF3B1 mutation predicts unfavorable treatment-free survival in Chinese chronic lymphocytic leukemia patients. Annals of Translational Medicine. 7(8). 176–176. 11 indexed citations
11.
Liu, Xinjian, Hao Yuan, Xiaoqiang Qi, et al.. (2019). Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death. Cancer Letters. 454. 204–214. 25 indexed citations
12.
Wei, Jishu, Xujun Song, Xinchun Liu, et al.. (2018). Glucagonoma and Glucagonoma Syndrome: One Center's Experience of Six Cases. SHILAP Revista de lepidopterología. 4(1). 11–16. 12 indexed citations
13.
Zou, Yixin, Lei Fan, Yi Xia, et al.. (2018). NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases. Cancer Medicine. 7(5). 1689–1696. 10 indexed citations
14.
Fan, Lei, Jin‐Hua Liang, Robert Peter Gale, et al.. (2018). Definition of disease‐progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables. Hematological Oncology. 36(4). 656–662. 2 indexed citations
15.
He, Lu, Jin‐Hua Liang, Jia‐Zhu Wu, et al.. (2016). Low absolute CD4+ T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma. Tumor Biology. 37(9). 12589–12595. 6 indexed citations
16.
Fan, Lei, Yi Miao, Yujie Wu, et al.. (2015). Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis. Leukemia & lymphoma. 56(12). 3329–3335. 23 indexed citations
19.
Miao, Yi, et al.. (2006). Dicationic DNA-targeted antiprotozoal agents: Naphthalene replacement of benzimidazole. Bioorganic & Medicinal Chemistry. 14(22). 7434–7445. 27 indexed citations
20.
Ismail, Mohamed A., Yi Miao, W. David Wilson, et al.. (2005). Dicationic near-linear biphenyl benzimidazole derivatives as DNA-targeted antiprotozoal agents. Bioorganic & Medicinal Chemistry. 13(24). 6718–6726. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026